(Q40648204)

22 September 2017

title

Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation (English)

1 reference

22 September 2017

main subject

human papilloma virus

object named as

human papilloma virus

1 reference

6

W Martin Kast

1 reference

22 September 2017

Minal T Kotecha

1

1 reference

22 September 2017

Razi K Afghan

2

1 reference

22 September 2017

Eleni Vasilikopoulou

3

1 reference

22 September 2017

Erica Wilson

4

1 reference

22 September 2017

Philip Marsh

5

1 reference

22 September 2017

D Huw Davies

7

1 reference

22 September 2017

Wilson Caparros-Wanderley

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

21

1 reference

22 September 2017

issue

19-20

1 reference

22 September 2017

page(s)

2506-2515

1 reference

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Empty MHC class I molecules come out in the cold

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5' untranslated leader

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Differential expression of influenza N protein and neuraminidase antigenic determinants in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

New and versatile cloning vectors with kanamycin-resistance marker.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Priming in vivo and quantification in vitro of class I MHC-restricted cytotoxic T cells to human papilloma virus type 11 early proteins (E6 and E7) using immunostimulating complexes (ISCOMs).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Incorporation of cells into an ELISA system enhances antigen-driven lymphokine detection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

The Tumor Enhancement Phenomenon: Reinterpretation From a Th1/Th2 Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Cytokine Dysregulation in Invasive Cervical Carcinoma and Other Human Neoplasias: Time to Consider the TH1/TH2 Paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Peptide analogs with different affinites for MHC alter the cytokine profile of T helper cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Prognostic Value of Intratumoral Interferon Gamma Messenger RNA Expression in Invasive Cervical Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900043-4

7 January 2021

10.1016/S0264-410X(03)00043-4

Identifiers

DOI

1 reference

22 September 2017

1 reference